NIP
SRPT icon

Nicholas Investment Partners’s Sarepta Therapeutics SRPT Stock Holding History

Nicholas Investment Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,514
Closed -$713K – 246
2024
Q2 		$713K Hold
4,514
– – 0.07% 173
2024
Q1 		$584K Buy
4,514
+1,185
+36% +$145K 0.06% 182
2023
Q4 		$321K Sell
3,329
-184,756
-98% -$17.7M 0.04% 186
2023
Q3 		$22.8M Buy
+188,085
New +$21.3M 1.7% 17
2023
Q2 		– Sell
-187,481
Closed -$25.8M – 209
2023
Q1 		$25.8M Buy
187,481
+97,091
+107% +$12.6M 1.96% 14
2022
Q4 		$11.7M Buy
+90,390
New +$10.5M 1.03% 40
2021
Q1 		– Sell
-78,970
Closed -$13.5M – 207
2020
Q4 		$13.5M Buy
78,970
+4,558
+6% +$675K 1.04% 31
2020
Q3 		$10.4M Buy
74,412
+61,844
+492% +$9.4M 1.13% 30
2020
Q2 		$2.02M Sell
12,568
-22,395
-64% -$3.05M 0.41% 95
2020
Q1 		$3.42M Sell
34,963
-753
-2% -$86.1K 0.67% 58
2019
Q4 		$4.61M Sell
35,716
-19,807
-36% -$2M 0.47% 64
2019
Q3 		$4.18M Buy
55,523
+1,368
+3% +$162K 0.35% 113
2019
Q2 		$8.23M Sell
54,155
-1,636
-3% -$199K 0.75% 34
2019
Q1 		$6.65M Sell
55,791
-18,311
-25% -$2.35M 0.59% 38
2018
Q4 		$8.09M Sell
74,102
-4,011
-5% -$502K 0.87% 21
2018
Q3 		$12.6M Buy
78,113
+19,570
+33% +$2.68M 1.01% 11
2018
Q2 		$7.74M Buy
+58,543
New +$5.52M 0.54% 43
2016
Q4 		– Sell
-38,504
Closed -$2.37M – 334
2016
Q3 		$2.37M Buy
+38,504
New +$1.16M 0.16% 244
2013
Q3 		– Sell
-51,046
Closed -$1.94M – 320
2013
Q2 		$1.94M Buy
+51,046
New +$1.83M 0.18% 182

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nicholas Investment Partners's SRPT Position: Q3 2024 in Review

Nicholas Investment Partners sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 4,514 shares — an estimated $713K sold.

Nicholas Investment Partners first reported a position in SRPT in Q2 2013 and held it in 19 quarters. The position peaked at $25.8M in Q1 2023. 458 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

  • Nicholas Investment Partners reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 4,514 Sarepta Therapeutics shares in Q3 2024, an estimated $713K.
  • Nicholas Investment Partners first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 19 quarters.
  • Nicholas Investment Partners's Sarepta Therapeutics position peaked at $25.8M in Q1 2023.
  • 458 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Nicholas Investment Partners's 13F filing for Q3 2024, filed 12 Nov 2024.